KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
3.0400
-0.0900 (-2.88%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.1300
Open3.1300
Bid3.0400 x 0
Ask3.0600 x 0
Day's Range3.0300 - 3.1400
52 Week Range0.8700 - 4.3500
Volume450,198
Avg. Volume1,259,196
Market Cap280.099M
Beta (3Y Monthly)3.58
PE Ratio (TTM)N/A
EPS (TTM)-0.4080
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
  • Are Insiders Buying Khiron Life Sciences Corp. (CVE:KHRN) Stock?
    Simply Wall St.2 hours ago

    Are Insiders Buying Khiron Life Sciences Corp. (CVE:KHRN) Stock?

    It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...

  • CNW Group12 days ago

    Khiron Provides Update on Transaction to Acquire NettaGrowth

    TORONTO , May 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of the Acquisition.

  • CNW Group15 days ago

    Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders

    Proxy voting deadline is May 29, 2019 at 11 a.m. ( Toronto time). Board of Directors recommends that Shareholders vote FOR all resolutions. TORONTO , May 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America, today announced it has commenced the mailing of the management information circular and other related materials (collectively, the "Meeting Materials") to Khiron's shareholders ("Shareholders") in connection with the annual general and special meeting of Shareholders (the "Meeting").

  • CNW Group19 days ago

    /C O R R E C T I O N from Source -- Khiron Life Sciences Corp./

    In the news release, Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing, issued 06-May-2019 by Khiron Life Sciences Corp. over CNW, we are advised by the company that the first paragraph, last sentence, should read "Common Share of $2.90 " rather than "Common Share of $3.00 " as originally issued inadvertently. TORONTO , May 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America , announced today that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, on behalf of a syndicate of underwriters (together, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, 8,621,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.90 (the "Issue Price") for gross proceeds of $25,000,900 (the "Offering").

  • Market Exclusive24 days ago

    Cannabis Stock News Daily Roundup May 1

    Panaxia Pharmaceutical Industries Israel and pharmaceutical company Rafa signed a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company. Under the agreement, the parties will co-develop the next generation of medical cannabis products intended for patients suffering from Inflammatory Bowel Disease, and who are authorized to receive treatment with medical cannabis. Khiron Life Sciences (TSXV: […]The post Cannabis Stock News Daily Roundup May 1 appeared first on Market Exclusive.

  • CNW Group24 days ago

    Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update

    Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update

  • Khiron Gets Kuida® Into Another 150 Stores
    PR Newswire25 days ago

    Khiron Gets Kuida® Into Another 150 Stores

    TORONTO, April 30, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has signed a distribution agreements for its Kuida® cosmeceutical brand with Cafam, a leading Colombian drugstore chain. This agreement further expands the brands points of sales In combination with the previous announced distribution arrangements this agreement further expands the brands retail and e-commerce points of sales in Colombia.

  • PR Newswire26 days ago

    Khiron Life Sciences Signs Letter of Intent to Establish Medical Cannabis Distribution Agreement for Over 900 pharmacies in Colombia

    LOI with Copservir Ltda, Colombia's largest pharmacy chain with over 900 pharmacies across 200 cities and municipalities across the country, and sales of over CAD 500 Million per year It is anticipated ...

  • Market Exclusive27 days ago

    Khiron Life Sciences to Acquire Italian Hemp Company

    Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF) has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. and a 100% stake interest in Campodoro S.r.l. – collective Canapalife Group – from shareholders Alvaro Garro and Paolo Puggioni. Khiron Seeking Opportunities in Europe Canapalife is a prominent hemp […]The post Khiron Life Sciences to Acquire Italian Hemp Company appeared first on Market Exclusive.

  • PR Newswirelast month

    Khiron Expands to Europe, Signs Non-Binding LOI to Acquire Italy-Based Canapalife Group

    TORONTO, April 25, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with its core operations in Latin America, announced today that the Company has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. Canapalife is a prominent hemp product company based in Italy with licenses for the cultivation, research, production and marketing of hemp-based products.

  • Dixie Brands to Host "Future of CBD & Cannabis" Lounge at New York City FounderMade Discovery Show
    CNW Grouplast month

    Dixie Brands to Host "Future of CBD & Cannabis" Lounge at New York City FounderMade Discovery Show

    DENVER , April 25, 2019 /CNW/ -  Dixie Brands  (CSE: DIXI.U), (OTC: DXBRF), ( Frankfurt : 0QV), one of the cannabis industry's leading consumer packaged goods ("CPG") companies, today announces a partnership with FounderMade to exclusively host the "Future of CBD & Cannabis" lounge at the FounderMade Discovery Show in New York City this coming June. Renowned for creating an environment where bold, innovative, life-changing products can thrive, the FounderMade Discovery Show is a summit for next generation companies to showcase groundbreaking products to key industry players. A pioneer in the category for the past ten years, Dixie's Future of CBD & Cannabis lounge will champion the cannabis plant and spotlight the industry as it emerges from prohibition and enters the mainstream.

  • CNW Grouplast month

    Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Expand Company's Leadership in Compliance and Security

    Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Expand ...

  • ACCESSWIRElast month

    Why Major Cannabis Companies Just Beginning to Expand in Latin America

    HOUSTON, TX / ACCESSWIRE / April 16, 2019 / The Latin America cannabis boom is just getting under way. As the second most populated country in Latin America, Mexico is home to 1.4 million cannabis users, with a market potential of $2 billion, for example. "With a potential count more than double Canada's, Colombia's medical marijuana market is quickly gaining recognition as a legitimate force in the global cannabis industry," notes Marijuana Business Daily.

  • Market Exclusivelast month

    Khiron, Colombian Hospital to Clinically Test Cannabis for Dermatological Conditions

    Khiron Life Sciences (TSXV:  KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) has entered into an agreement with the prominent Colombian research hospital Centro Dermatológico Federico Lleras Acosta (CDFLLA) to test the effectiveness of medical cannabis for dermatological conditions. Cannabis for Skin Care Under the agreement, Khiron and CDFLLA will establish a clinical research partnership focused on the […]The post Khiron, Colombian Hospital to Clinically Test Cannabis for Dermatological Conditions appeared first on Market Exclusive.

  • Market Exclusivelast month

    Cannabis Stock News Daily Roundup April 12

    Crop Infrastructure (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) has started the application process for its two retail applications for its Emerald Heights brand in California, one in Chula Vista and the other in Contra Costa. Cannvas MedTech (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF) has formed a partnership with California-based interactive customer-focused cannabis education platform Seed Technology […]The post Cannabis Stock News Daily Roundup April 12 appeared first on Market Exclusive.

  • GlobeNewswirelast month

    The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness  

    Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum. According to one report from the GlobalWellnessInstitute, “a wellness mindset is starting to permeate the global consumer consciousness, affecting people’s daily decision-making – whether food purchases, a focus on mental wellness and reducing stress, incorporating movement into daily life, environmental consciousness, or their yearning for connection and happiness,” noted Katherine Johnston, senior research fellow, GWI. This change in mindset combined with growing interest from large retailers, most recently CVS and Walgreens, is making many companies invest in beauty and wellness.

  • CNW Grouplast month

    Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market

    TORONTO , April 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that it has entered into an agreement with the prominent Colombian research hospital, Centro Dermatológico Federico Lleras Acosta ("CDFLLA"). Pursuant to the terms of the agreement, Khiron and CDFLLA will establish a clinical research partnership focused on the effectiveness of medical cannabis for dermatological conditions.

  • CNW Group2 months ago

    IIROC Trading Resumption - KHRN

    IIROC Trading Resumption - KHRN

  • PR Newswire2 months ago

    Khiron Advances Multi-Country Operator Strategy by Signing Definitive Agreement to Acquire Licence in Uruguay

    TORONTO, April 9, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Latin America, announced today that it has signed a definitive agreement for the acquisition of NettaGrowth International Inc. ("NettaGrowth"), as previously announced on January 25, 2019. NettaGrowth will, at the time of the closing of the acquisition, own all of the outstanding shares of Dormul S.A. ("Dormul"), a Uruguayan company that has obtained the first licence to produce and export medical cannabis with THC for commercialization in Uruguay.